LLY

971.9

-2.91%↓

JNJ

237.23

-3.12%↓

ABBV

229.66

-2.43%↓

NVS

160.05

-2.76%↓

AZN

195.63

-3.22%↓

LLY

971.9

-2.91%↓

JNJ

237.23

-3.12%↓

ABBV

229.66

-2.43%↓

NVS

160.05

-2.76%↓

AZN

195.63

-3.22%↓

LLY

971.9

-2.91%↓

JNJ

237.23

-3.12%↓

ABBV

229.66

-2.43%↓

NVS

160.05

-2.76%↓

AZN

195.63

-3.22%↓

LLY

971.9

-2.91%↓

JNJ

237.23

-3.12%↓

ABBV

229.66

-2.43%↓

NVS

160.05

-2.76%↓

AZN

195.63

-3.22%↓

LLY

971.9

-2.91%↓

JNJ

237.23

-3.12%↓

ABBV

229.66

-2.43%↓

NVS

160.05

-2.76%↓

AZN

195.63

-3.22%↓

Начало・Списък с акции・Pliant Therapeutics Inc

Pliant Therapeutics Inc

Отворен

1.29

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

1.26

Максимум

1.31

Ключови измерители
By Trading Economics
Приходи	17M -26M
Служители	171
EBITDA	19M -23M

Препоръки
By TipRanks
Препоръки	Неутрален
12-месечна прогноза	+60% upside

Дивиденти
By Dow Jones
Следващи печалби	5.03.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	-24M 78M
Предишно отваряне	1.29
Предишно затваряне	1.29

Техническа оценка

By Trading Central

Увереност

Very Strong Bearish Evidence

1.43 / 1.6 Подкрепа & съпротива

Pliant Therapeutics Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

4.03.2026 г., 23:39 ч. UTC

Горещи акции

Stocks to Watch: Broadcom, StubHub, PepGen, Veeva Systems

4.03.2026 г., 23:20 ч. UTC

Печалби

Broadcom Sales Rise as AI Developers Build More Products and Agents -- Update

4.03.2026 г., 21:43 ч. UTC

Печалби

Broadcom Logs Higher Sales, Authorizes $10 Billion Buyback Amid Climbing AI Demand

4.03.2026 г., 23:48 ч. UTC

Пазарно говорене

Nikkei May Rise After Recent Selloffs -- Market Talk

4.03.2026 г., 23:33 ч. UTC

Пазарно говорене

Значими събития в новините

Gold Edges Higher Amid Ongoing U.S.-Iran Conflict -- Market Talk

4.03.2026 г., 23:24 ч. UTC

Пазарно говорене

RBA on Track to Raise Rates, but What's the Rush? -- Market Talk

4.03.2026 г., 22:30 ч. UTC

Печалби

Ecopetrol: Distribution Equivalent to a Payout of 50.1% of Ecopetrol S.A.'s Net Income in 2025 >EC

4.03.2026 г., 22:30 ч. UTC

Печалби

Ecopetrol: Payment of Dividends Proposed to Be Made No Later Than April 30 >EC

4.03.2026 г., 22:30 ч. UTC

Печалби

Ecopetrol: Earnings Distribution Proposes Ordinary Div Distribution of COP110 per Shr >EC

4.03.2026 г., 22:13 ч. UTC

Печалби

Vermilion Energy: Expects Full-Yr Production of 118,000 to 122,000 Boe/d (70% Natural Gas) >VET

4.03.2026 г., 22:13 ч. UTC

Печалби

Vermilion Energy: Expects 1Q Production to Avg 122,000 to 124,000 Boe/d (70% Natural Gas) >VET

4.03.2026 г., 22:13 ч. UTC

Печалби

Vermilion Energy 4Q EPS C$2.86 >VET

4.03.2026 г., 22:04 ч. UTC

Пазарно говорене

RBA Slipping Behind The Curve On Rates -- Market Talk

4.03.2026 г., 21:53 ч. UTC

Печалби

Lithium Americas 4Q Rev $66.8M >LAC

4.03.2026 г., 21:53 ч. UTC

Печалби

Lithium Americas 4Q Loss/Shr 52c >LAC

4.03.2026 г., 21:52 ч. UTC

Печалби

Broadcom Earnings Beat Estimates as AI Demand Remains Strong -- Barrons.com

4.03.2026 г., 21:50 ч. UTC

Печалби

These Stocks Are Today's Movers: Moderna, Coinbase, Strategy, CoreWeave, Micron, Sandisk, GitLab, and More -- Barrons.com

4.03.2026 г., 21:50 ч. UTC

Пазарно говорене

Tech, Media & Telecom Roundup: Market Talk

4.03.2026 г., 21:48 ч. UTC

Печалби

Webull 4Q Rev $165.2M >BULL

4.03.2026 г., 21:48 ч. UTC

Печалби

Webull 4Q EPS 1c >BULL

4.03.2026 г., 21:45 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

4.03.2026 г., 21:45 ч. UTC

Пазарно говорене

Canada Officials Might Need to Intervene to Spur Home Building -- Market Talk

4.03.2026 г., 21:40 ч. UTC

Печалби

Broadcom Earnings Beat Estimates as AI Demand Remains Strong -- Barrons.com

4.03.2026 г., 21:36 ч. UTC

Значими събития в новините

Iran Conflict Spurs Rebound in U.S. Borrowing Costs -- Update

4.03.2026 г., 21:27 ч. UTC

Печалби

Broadcom Earnings Beat Estimates as AI Demand Remains Strong -- Barrons.com

4.03.2026 г., 21:17 ч. UTC

Пазарно говорене

Energy Price Volatility Boosts Case for Climate-Tech Startups -- Market Talk

4.03.2026 г., 21:16 ч. UTC

Печалби

Broadcom: Board Authorizes Share-Repurchase Program for Up to $10B of Common Stock >AVGO

4.03.2026 г., 21:15 ч. UTC

Печалби

Broadcom 1Q EPS $1.50 >AVGO

4.03.2026 г., 21:15 ч. UTC

Печалби

Broadcom 1Q Net $7.35B >AVGO

4.03.2026 г., 21:15 ч. UTC

Печалби

Broadcom 1Q Rev $19.31B >AVGO

Сравнение с други в отрасъла

Ценова промяна

Pliant Therapeutics Inc Прогноза

Ценова цел

By TipRanks

60% нагоре

12-месечна прогноза

Среден 2 USD 60%

Висок 2 USD

Нисък 2 USD

Според 1 анализатори от Wall Street, предложили 12-месечна ценова цел за Pliant Therapeutics Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Неутрален

1 ratings

Купи

Задържане

Продай

Според 1 анализатори, дали борсови рейтинги на Pliant Therapeutics Inc през последните 3 месеца.

Техническа оценка

By Trading Central

1.43 / 1.6Подкрепа & съпротива

Recent bearish events outweigh bullish events.

There is one bearish event.

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Pliant Therapeutics Inc

Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. The company's lead candidate is bexotegrast, an oral, small-molecule, dual selective inhibitor of avß6 and avß1 integrins, which is in phase 2b trials for idiopathic pulmonary fibrosis and in phase 2a trial for primary sclerosing cholangitis. It also develops PLN-1474, an oral, small-molecule selective inhibitor of avß1 for the treatment of liver fibrosis associated with nonalcoholic steatohepatitis; PLN-101095, a dual inhibitor of integrins avß8 and avß1 for the treatment of solid tumors; and PLN-101325 for treatment of muscular dystrophies. Pliant Therapeutics, Inc. was incorporated in 2015 and is based in South San Francisco, California.